Announcements Trials
Browse Landscape

Phase

Phase 2 137Phase 3 51Phase 1 43Phase 1/2 33Phase 2/3 7Phase NA 4Phase EARLY_PHASE1 1Phase 4 1

Status

Unknown 3Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1NETWORK 1INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 10Stomach Neoplasms 8Prostatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Gastrointestinal Neoplasms 3Neoplasms 2Head and Neck Neoplasms 2HER2-positive Breast Cancer 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Non-small Cell Lung Cancer 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Progression Free Survival 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1HER2-negative Breast Cancer 1FGFR1 Gene Amplification 1

Interventions

Docetaxel 7acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Prednisone 5Androgen Antagonists 5gallium 68 PSMA-11 4enzalutamide 3bicalutamide 3Triptorelin Pamoate 3Radiosurgery 3Leuprolide 3Goserelin 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3abiraterone 2Zoledronic Acid 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Mitoxantrone 2Flutamide 2Celecoxib 2Abiraterone Acetate 2satraplatin 1relugolix 1pertuzumab 1nilutamide 1maltodextrin 1luprolide acetate gel depot 1histrelin 1genistein combined polysaccharide 1fluciclovine F-18 1darolutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2/3 × Prostatic Neoplasms × Docetaxel × Clear all
NCT06282588 2026-03-19

THUNDER

Cancer Research Antwerp

Phase 2/3 Recruiting
493 enrolled
Genitourinary

Prostatic Neoplasms

NCT03258320 2026-01-12

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Shanghai Jiao Tong University School of Medicine

Phase 2/3 Recruiting
300 enrolled
Genitourinary

Prostatic Neoplasms

NCT05627752 2024-02-28

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Zhongnan Hospital

Phase 2/3 Unknown
120 enrolled
Genitourinary

Prostatic Neoplasms

NCT00268476 2023-04-18

STAMPEDE

Medical Research Council

Phase 2/3 Active not recruiting
11,992 enrolled
Genitourinary

Prostatic Neoplasms

NCT03879122 2022-10-26

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

Spanish Oncology Genito-Urinary Group

Phase 2/3 Unknown
135 enrolled
Genitourinary

Prostatic Neoplasms

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00043576 2009-03-12

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Novacea

Phase 2/3 Unknown
250 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡